Philippines: Regulating vaping

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Philippines: Regulating vaping

Earlier in 2014, the DOH issued Administrative Order No. 2014-0008, requiring all manufacturers or distributors of e-cigarettes or vapes to apply for Certificate of Product Registration (CPR) after passing quality checks before the products can be sold in the Philippine market, classifying the products as health or consumer products under the jurisdiction of the Food and Drug Administration (FDA). Local government units (LGU's), such as Baguio City, however, are free to pass their own ordinances independent of the FDA.

baguio.jpg

Notwithstanding this administrative order (AO), vape outlets continue to proliferate without seeking CPRs from the FDA. Hence, on June 14 2019, the DOH issued Administrative Order No. 2019-0007, entitled Revised Rules on Electronic Nicotine and Non-Nicotine Delivery Systems (ENDS/ENNDS). This order prescribed regulations on the manufacture and sale of nicotine and non-nicotine delivery systems, popularly known as e-cigarettes, which are being marketed as safer alternatives to combustible cigarettes and was published on July 9 2019, taking effect on July 24 2019. The DOH gave makers, sellers, distributors, importers and exporters of ENDS/ENNDS three months or until October to comply with the revised regulations and register with the FDA, or their products could be confiscated, and they run the risk of being barred from selling these products in the Philippines.

AO 2019-0007 supports Executive Order No. 26 issued by President Duterte which imposed, from 2017, a ban on cigarette and tobacco smoking in public places, by including vaping or the use of e-cigarettes or electronic nicotine and non-nicotine delivery systems (ENDS) implemented nationwide. The DOH also wants containers of ENDS products to incorporate the labelling warning requirements imposed on cigarettes, but the regulations are not yet clear on how this would appear.

On November 7 2019, the FDA announced the temporary suspension on the implementation of AO 2019-0007 to comply with the writ of preliminary injunction issued by the regional trial court of Pasig City on September 26 2019, enjoining the DOH and FDA from implementing the AO. The action was filed by Planet Vape, a seller, which prides itself as "a one-stop shop that caters to all types of vapers – from newbies to modified users…"

With this development, the FDA is placing all applications for a licence to operate and product registration on hold until the court resolves the issue. It is reported that there are industry association and consumer groups lobbying in favour of vaping, for example, the Philippine E-Cigarette Industry Association (PECIA), the Philippine E-Liquid Manufacturers Association of the Philippines, Inc. (PEMA) and the consumer groups, The Vapers Philippines (TVP), Vapers Association of the Philippines (VAP), and the United Vapers Alliance (UVA) consisting of vape users and manufacturers. These organisations are for regulating the vaping industry, and claim that e-cigarettes are safer alternatives to smoking, should not be treated similarly to tobacco products and that individuals have the "right to vape." In an interview on a TV show, the UVA president claims to be representing small businesses, and working with the FDA and the Department of Trade and Industry (DTI) for the issuance of the necessary regulations for e-cigarettes. There is also a move to remove the regulation of ENDS from the FDA which imposes stricter controls, to the DTI which regulates consumer products. However, the DTI's jurisdiction is limited to prime commodities or basic necessities such as food, cement, steel, etc.

There are a number of pending proposed laws filed with the Philippine Congress, all designed to regulate ENDS such as: House Bill (HB) Nos. 532, 4325, 4810, 3330, 7289, 1744, 7935, 7993, and Senate Bill (SB) Nos. 1538, 1744, and there may still be other bills. These bills have different definitions of ENDS, and the commonality is in the reference to ENDS as a product with or without tobacco. Some have viewed these bills as a way of weakening the regulations on tobacco products.

Public health or the right to trade? It seems that the vaping community and its champions have to really show convincing evidence that vaping is indeed the safer alternative to smoking, and should not be as heavily regulated as the tobacco industry.

hechanova-editha.jpg

Editha R

Hechanova


Hechanova & Co., Inc.Salustiana D. Ty Tower104 Paseo de Roxas AvenueMakati City 1229, PhilippinesTel: (63) 2 812-6561Fax: (63) 2 888-4290editharh@hechanova.com.ph 

www.hechanova.com.ph

more from across site and SHARED ros bottom lb

More from across our site

The firm said adding capability in the French capital completes its coverage of all major patent litigation jurisdictions as it strives for UPC excellence
Marc Fenster explains how keeping the jury focused on the most relevant facts helped secure a $279m win for his client against Samsung
Clients are divided on what externally funded IP firms bring to the table, so those firms must prove why the benefits outweigh the downsides
Rahul Bhartiya, AI coordinator at the EUIPO, discusses the office’s strategy, collaboration with other IP offices, and getting rid of routine tasks
A boom in transactional work and a heightened awareness of IP have helped boost revenue for the rebranded commercial services team
Clemens Heusch, head of global litigation and dispute resolution at Nokia, tells us why open conversations – and respectful challenges – lead to the best results
Siegmund Gutman, who joined Mintz one year ago, explains the firm’s approach to life sciences litigation and what it means for hiring plans
The merger of two IP boutiques could prompt others to follow suit and challenge Australia’s externally funded firms
Law firm leaders say they are eager to make the most out of the market following a 'surprising' survey on in-house interest in IP monetisation
A defeat for AstraZeneca and Open Innovation Network's 20th anniversary were also among the top talking points this week
Gift this article